To overcome these drawbacks, they reported that PEGylated (HS–PEG–COOH) antibody was conjugated to the HER2 monoclonal antibody to target PEGylated AuNP-C11Pc conjugate to breast cancer cells. This evidence concerns the gene ERBB2 and breast carcinoma.